Log In
BCIQ
Print this Print this
 

IMM65

  Manage Alerts
Collapse Summary General Information
Company iOx Therapeutics
DescriptionSynthetic lipid compound that activates natural killer T cells
Molecular Target Natural killer T cells
Mechanism of Action 
Therapeutic ModalityMacromolecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today